UA83932U - Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis - Google Patents

Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis

Info

Publication number
UA83932U
UA83932U UAU201302418U UAU201302418U UA83932U UA 83932 U UA83932 U UA 83932U UA U201302418 U UAU201302418 U UA U201302418U UA U201302418 U UAU201302418 U UA U201302418U UA 83932 U UA83932 U UA 83932U
Authority
UA
Ukraine
Prior art keywords
combined
chronic obstructive
patients
lungs
treatment
Prior art date
Application number
UAU201302418U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Кирилл Николаевич Лебедь
Юрий Николаевич Колчин
Евгений Дмитриевич Андросов
Original Assignee
Кирилл Николаевич Лебедь
Юрий Николаевич Колчин
Евгений Дмитриевич Андросов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кирилл Николаевич Лебедь, Юрий Николаевич Колчин, Евгений Дмитриевич Андросов filed Critical Кирилл Николаевич Лебедь
Priority to UAU201302418U priority Critical patent/UA83932U/en
Publication of UA83932U publication Critical patent/UA83932U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method for treating patients with chronic obstructive pulmonary disease, combined with non-alcoholic steatohepatitis, comprising administering of antimicrobials, mucolytics, systemic and inhaled corticosteroids, inhaled bronchodilators, aminophylline H, hepatoprotective drugs and immunoactive agents. As the drug Essliver forte with hepatoprotective properties is administered and further - Roflumilast with anti-inflammatory action.
UAU201302418U 2013-02-26 2013-02-26 Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis UA83932U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201302418U UA83932U (en) 2013-02-26 2013-02-26 Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201302418U UA83932U (en) 2013-02-26 2013-02-26 Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis

Publications (1)

Publication Number Publication Date
UA83932U true UA83932U (en) 2013-10-10

Family

ID=52283291

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201302418U UA83932U (en) 2013-02-26 2013-02-26 Method for treatment of patients with chronic obstructive disease of lungs combined with nonalcoholic steatohepatitis

Country Status (1)

Country Link
UA (1) UA83932U (en)

Similar Documents

Publication Publication Date Title
ZA202103404B (en) Composition and method for treating the lungs
MX2019006938A (en) Methods and compositions for treatment of pulmonary hypertension and other lung disorders.
SA520411119B1 (en) Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof
BRPI0606736A2 (en) combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
WO2014205229A8 (en) Use of high dose pridopidine for treating huntington's disease
NZ714963A (en) Compositions and methods for treating anemia
BR112013029246A2 (en) 4-amino-5-fluoro-3- [6- (4-methylpiperazin-1-yl) -1h-benzimidazol-2-yl] -1h-quinolin-2-one for use in the treatment of adenoid cystic carcinoma
RU2014141893A (en) APPLICATION OF THE PYRAZOLE DERIVATIVE IN THE TREATMENT OF ACUTE ACTIONS OF CHRONIC OBSTRUCTIVE LUNG DISEASE
MX2018006247A (en) Methods for treating alzheimer's disease and related disorders.
NZ606993A (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
NZ606977A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
WO2016090024A3 (en) Combination therapy for treatment of cancer
MY188179A (en) Tiotropium inhalation solution for nebulization
MD4369C1 (en) Use of glycopyrrolate for treating tachycardia, unit dose, delivery device, method of treatment and prophylaxis of tachycardia
JP2015522603A5 (en)
JP2007119497A5 (en)
JP2017061488A5 (en)
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
EA201591415A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING MULTICOMPONENT CRYSTALLINE PARTICLES, SUITABLE FOR USE IN INHALATION THERAPY
UA122336C2 (en) Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function
WO2016025671A3 (en) Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist
JP2016503035A5 (en)
MX2020010977A (en) Methods of treating fungal infections.
MX2018013475A (en) Carboxylic acid for treating/preventing nasal congestion.